1. "New England Journal of Medicine"
  2. "2022"
Formats
  1. Journal Article (16)
  2. Correspondence (6)
  3. Editorial (5)
Groups
  1. Department of Medicine (19)
  2. Center for Hematologic Malignancies (10)
  3. Hematologic Malignancies, Division of (10)
  4. Solid Tumor Oncology Division (9)
  5. Survivorship Research (6)
  6. Lymphoma (5)

More Groups

People
  1. Sham Mailankody (3)
  2. Andrea Cercek Hanjis (2)
  3. Bob Li (2)
  4. David Straus (2)
  5. Hani Hassoun (2)
  6. Jae Park (2)

More People

Years
  1. 2022 (27)
Publications
  1. New England Journal of Medicine (27)
Publishers
  1. Massachusetts Medical Society (27)

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effect of colonoscopy screening on risks of colorectal cancer and related death
    Journal Article

    Bretthauer, M.; Loberg, M.; Wieszczy, P.; Kalager, M.; Emilsson, L.; Garborg, K.; Rupinski, M.; Dekker, E.; Spaander, M.; Bugajski, M.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • GPRC5D-targeted CAR T cells for myeloma: The author's reply
    Correspondence

    Mailankody, S.; Brentjens, R. J.; Smith, E. L.
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Click here for better chemistry
    Editorial

    Zeglis, B. M.; Lewis, J. S.
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Prostate cancer screening with PSA and MRI followed by targeted biopsy only
    Journal Article

    Hugosson, J.; Månsson, M.; Wallström, J.; Axcrona, U.; Carlsson, S. V.; Egevad, L.; Geterud, K.; Khatami, A.; Kohestani, K.; Pihl, C. G.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Brentuximab vedotin in advanced Hodgkin's lymphoma: The authors reply
    Correspondence

    Ansell, S. M.; Radford, J.; Straus, D. J.
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • GPRC5D-targeted CAR T cells for myeloma
    Journal Article

    Mailankody, S.; Devlin, S. M.; Landa, J.; Nath, K.; Diamonte, C.; Carstens, E. J.; Russo, D.; Auclair, R.; Fitzgerald, L.; Cadzin, B.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Teclistamab in relapsed or refractory multiple myeloma
    Journal Article

    Moreau, P.; Garfall, A. L.; van de Donk, N. W. C. J.; Nahi, H.; San-Miguel, J. F.; Oriol, A.; Nooka, A. K.; Martin, T.; Rosinol, L.; Chari, A.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Adagrasib in non-small-cell lung cancer harboring a KRAS(G12C) mutation
    Journal Article

    Jänne, P. A.; Riely, G. J.; Gadgeel, S. M.; Heist, R. S.; Ou, S. H. I.; Pacheco, J. M.; Johnson, M. L.; Sabari, J. K.; Leventakos, K.; Yau, E.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan in HER2-low breast cancer - The authors reply
    Correspondence

    Modi, S.; Gambhire, D.; Cameron, D.
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • PD-1 blockade in mismatch repair-deficient rectal cancer - The authors reply
    Correspondence

    Cercek, A.; Diaz, L. A. Jr
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save